Commission Implementing Regulation (EU) 2023/515 of 8 March 2023 renewing the approval of the active substance abamectin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
Article 3Entry into force and date of application
In force · version of Mar 12, 2023
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union .
It shall apply from 1 April 2023.